Which early indicator allows for a better understanding of the evolution of the COVID-19 epidemic in France?

Patrice Loisel

doi:10.1101/2020.09.29.20203760

Abstract

We provide an explanation for the apparent discrepancy between the dynamic of the positive COVID-19 test rates and of the numbers of COVID-19-related hospital and intensive care admissions and deaths in France. We highlight the existence of a latency period of around 5 weeks between the positive detection rate and the number of new admissions (in the exponential phase of the positive detection rate evolution). If the overall positive detection rate provided relevant information until the end of August, since the beginning of September the overall positive detection rate has reached a plateau and no longer provides relevant information on the current state of the epidemic. We show that the positive detection rate in the 70+ age group is a relevant and early indicator of the epidemic.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by INRAE

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data is free of copyright

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.